Login / Signup

In vitro α-amylase inhibitory effect of TLC isolates of Aloe megalacantha baker and Aloe monticola Reynolds.

Gebretsadkan Hintsa TekuluEphrem Mebrahtu ArayaHayelom Gebrekirstos Mengesha
Published in: BMC complementary and alternative medicine (2019)
Hence, the outcomes of the present investigation partly justify the acclaimed use of Aloe megalacantha and Aloe monticola for the treatment of diabetes.
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • adipose tissue
  • metabolic syndrome
  • combination therapy